{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-082900","form_type":"8-K","ticker":"OSUR","cik":"0001116463","company_name":"ORASURE TECHNOLOGIES INC","filed_at":"2022-03-23T23:59:59+00:00","discovered_at":"2026-05-14T18:04:05.467141+00:00","generated_at":"2026-06-26T19:18:28.679810+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"OraSure appoints Nancy Gagliano as Interim CEO effective April 1, 2022; Stephen Tang terminated","bullets":["Dr. Gagliano, a current director, becomes Interim CEO after Stephen Tang's termination as CEO and director on March 31, 2022.","Compensation includes monthly base salary of $55,833, $100k fully vested stock grant, and $670k RSU award vesting monthly over 12 months.","Board size reduced from 10 to 9 members effective April 1, 2022.","Dr. Gagliano will not participate in annual incentive or long-term incentive plans; non-employee director fees cease during tenure."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-082900","json":"https://secwatch.observer/filing/0001193125-22-082900.json","markdown":"https://secwatch.observer/filing/0001193125-22-082900.md","text":"https://secwatch.observer/filing/0001193125-22-082900.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1116463/000119312522082900/0001193125-22-082900-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1116463/000119312522082900/d332944d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T19:18:28.679810+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"906a1f839b","claim":"Nancy J. Gagliano was appointed as Interim Chief Executive Officer at ORASURE TECHNOLOGIES INC.","evidence_excerpt":"appointed Nancy J. Gagliano, M.D., M.B.A., a current director of the Company, to serve as the Company’s Interim Chief Executive Officer","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1116463/000119312522082900/0001193125-22-082900-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Interim Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"b820d5df5b","claim":"Stephen S. Tang was terminated as President and Chief Executive Officer at ORASURE TECHNOLOGIES INC.","evidence_excerpt":"following the termination of Stephen S. Tang as a director and the Company’s President and Chief Executive Officer on March 31, 2022","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1116463/000119312522082900/0001193125-22-082900-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"terminated"},{"label":"Role","value":"President and Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}